Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) CEO Amit Gupta sold 6,498 shares of the stock in a transaction on Thursday, July 2nd. The stock was sold at an average price of $4.39, for a total value of $28,526.22. Following the completion of the transaction, the chief executive officer owned 123,490 shares of the company’s stock, valued at $542,121.10. The trade was a 5.00% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.
Amit Gupta also recently made the following trade(s):
- On Monday, July 6th, Amit Gupta sold 9,640 shares of Cardlytics stock. The stock was sold at an average price of $4.39, for a total transaction of $42,319.60.
Cardlytics Price Performance
Shares of NASDAQ CDLX traded down $0.10 during trading on Monday, hitting $4.37. 58,856 shares of the company were exchanged, compared to its average volume of 103,822. Cardlytics, Inc. has a 1 year low of $4.25 and a 1 year high of $32.80. The company has a market cap of $25.39 million, a price-to-earnings ratio of -0.25 and a beta of 0.61. The firm’s fifty day moving average price is $6.37 and its 200 day moving average price is $8.75.
Analysts Set New Price Targets
Check Out Our Latest Research Report on Cardlytics
Institutional Trading of Cardlytics
Several institutional investors and hedge funds have recently modified their holdings of the business. Bank of America Corp DE grew its position in shares of Cardlytics by 262.7% in the third quarter. Bank of America Corp DE now owns 1,632,786 shares of the company’s stock valued at $3,968,000 after purchasing an additional 1,182,593 shares during the last quarter. Quinn Opportunity Partners LLC raised its position in shares of Cardlytics by 900.0% during the 3rd quarter. Quinn Opportunity Partners LLC now owns 1,100,000 shares of the company’s stock worth $2,673,000 after purchasing an additional 990,000 shares during the last quarter. Geode Capital Management LLC lifted its stake in Cardlytics by 3.3% in the 4th quarter. Geode Capital Management LLC now owns 654,472 shares of the company’s stock valued at $753,000 after buying an additional 20,908 shares in the last quarter. UBS Group AG lifted its stake in Cardlytics by 112.5% in the 3rd quarter. UBS Group AG now owns 458,066 shares of the company’s stock valued at $1,113,000 after buying an additional 242,536 shares in the last quarter. Finally, Invesco Ltd. grew its holdings in Cardlytics by 38.1% during the 4th quarter. Invesco Ltd. now owns 170,122 shares of the company’s stock valued at $196,000 after buying an additional 46,973 shares during the last quarter. Hedge funds and other institutional investors own 68.10% of the company’s stock.
About Cardlytics
Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.
At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.
See Also
- Five stocks we like better than Cardlytics
- Flash Crash or Cash? The AI Hardware Reset Investors Can’t Ignore
- As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner
- KBR Insiders Are Buying While the Market Misreads Its Spinoff
- Contrarian Alert: 5 Downgraded Stocks That May Reward Long-Term Investors
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.
